Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:54:50 EST Tue 02 Dec 2025
Enter Symbol
or Name
USA
CA



Q:CRMD - CORMEDIX INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRMD - Q9.49.73·9.772.49.78-0.01-0.12,457.323,38810,8219.91  10.10  9.67517.43  5.6016:33:52Nov 1215 min RT 2¢

Recent Trades - Last 10 of 10821
Time ETExPriceChangeVolume
16:33:52Q9.77-0.021,000
16:19:10Q9.77-0.021
16:12:47Q9.78-0.011
16:10:04Q9.78-0.011
16:10:04Q9.78-0.011
16:04:13Q9.78-0.011
16:04:13Q9.78-0.011
16:04:11Q9.78-0.011
16:04:11Q9.78-0.011
16:04:10Q9.78-0.011

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-11-12 16:05U:CRMDNews ReleaseTalphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
2025-11-12 11:01U:CRMDNews ReleaseStrong Earnings and Biotech Resilience Define the Midweek Momentum
2025-11-12 07:30U:CRMDNews ReleaseCorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
2025-10-31 08:30U:CRMDNews ReleaseCorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
2025-10-23 08:30U:CRMDNews ReleaseCorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
2025-10-21 08:30U:CRMDNews ReleaseTalphera Announces the Appointment of Joe Todisco to Board of Directors
2025-10-20 07:30U:CRMDNews ReleaseCorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
2025-09-29 08:30U:CRMDNews ReleaseCorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
2025-09-08 08:30U:CRMDNews ReleaseTalphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
2025-09-08 08:30U:CRMDNews ReleaseCorMedix Announces Strategic Minority Investment in Talphera
2025-09-02 07:30U:CRMDNews ReleaseCorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
2025-08-28 08:30U:CRMDNews ReleaseCorMedix to Participate in Upcoming Investor Conferences
2025-08-07 07:00U:CRMDNews ReleaseCormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-08-07 07:00U:CRMDNews ReleaseCorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
2025-06-27 08:00U:CRMDNews ReleaseCorMedix Inc. Announces Pricing of Public Offering of Common Stock
2025-06-26 16:01U:CRMDNews ReleaseCorMedix Inc. Announces Proposed Public Offering of Common Stock
2025-06-23 07:30U:CRMDNews ReleaseCorMedix inc. Announces Customer Implementation
2025-05-30 08:30U:CRMDNews ReleaseCorMedix Inc. To Participate In The Jefferies Global Healthcare Conference
2025-05-15 08:30U:CRMDNews ReleaseCorMedix Inc. to Participate in the RBC Global Healthcare Conference
2025-05-06 07:30U:CRMDNews ReleaseCorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update